机译:BRD4作为无障碍和生长激素垂体腺瘤的治疗靶标
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Chinese Acad Sci Drug Discovery & Design Ctr CAS Key Lab Receptor Res State Key Lab Drug Res Shanghai Inst Mat Med Shanghai Peoples R China;
Chinese Acad Sci Drug Discovery & Design Ctr CAS Key Lab Receptor Res State Key Lab Drug Res Shanghai Inst Mat Med Shanghai Peoples R China|Zhejiang Sci Tech Univ Coll Life Sci Hangzhou Peoples R China;
Chinese Acad Sci Drug Discovery & Design Ctr CAS Key Lab Receptor Res State Key Lab Drug Res Shanghai Inst Mat Med Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Chinese Acad Sci Drug Discovery & Design Ctr CAS Key Lab Receptor Res State Key Lab Drug Res Shanghai Inst Mat Med Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China|Fudan Univ State Key Lab Med Neurobiol Inst Brain Sci Shanghai Peoples R China|Fudan Univ MOE Frontiers Ctr Brain Sci Inst Brain Sci Shanghai Peoples R China|Fudan Univ Huashan Hosp Natl Clin Res Ctr Aging & Med Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
Shanghai Pituitary Tumor Ctr Shanghai Peoples R China|Fudan Univ Huashan Hosp Shanghai Med Coll Dept Endocrinol Shanghai Peoples R China;
Shanghai Pituitary Tumor Ctr Shanghai Peoples R China|Fudan Univ Huashan Hosp Shanghai Med Coll Dept Endocrinol Shanghai Peoples R China;
Shanghai Pituitary Tumor Ctr Shanghai Peoples R China|Fudan Univ Huashan Hosp Shanghai Med Coll Dept Endocrinol Shanghai Peoples R China;
Shanghai Pituitary Tumor Ctr Shanghai Peoples R China|Fudan Univ Huashan Hosp Shanghai Med Coll Dept Endocrinol Shanghai Peoples R China;
Shanghai Pituitary Tumor Ctr Shanghai Peoples R China|Fudan Univ Huashan Hosp Shanghai Med Coll Dept Pathol Shanghai Peoples R China;
Shanghai Pituitary Tumor Ctr Shanghai Peoples R China|Fudan Univ Huashan Hosp Shanghai Med Coll Dept Pathol Shanghai Peoples R China;
Wenzhou Med Univ Dept Neurosurg Cent Hosp Wenzhou Affiliated Dingli Clin Inst Wenzhou Zhejiang Peoples R China;
Wenzhou Med Univ Dept Neurosurg Cent Hosp Wenzhou Affiliated Dingli Clin Inst Wenzhou Zhejiang Peoples R China;
Shanghai Jiao Tong Univ Key Lab Cell Differentiat & Apoptosis Shanghai Inst Immunol Chinese Minist Educ Sch Med Shanghai Peoples R China;
Zhejiang Sci Tech Univ Coll Life Sci Hangzhou Peoples R China;
Chinese Acad Sci Drug Discovery & Design Ctr CAS Key Lab Receptor Res State Key Lab Drug Res Shanghai Inst Mat Med Shanghai Peoples R China;
Chinese Acad Sci Drug Discovery & Design Ctr CAS Key Lab Receptor Res State Key Lab Drug Res Shanghai Inst Mat Med Shanghai Peoples R China;
Chinese Acad Sci Drug Discovery & Design Ctr CAS Key Lab Receptor Res State Key Lab Drug Res Shanghai Inst Mat Med Shanghai Peoples R China|China Pharmaceut Univ Dept Med Chem Nanjing Peoples R China;
Fudan Univ Huashan Hosp Shanghai Med Coll Dept Neurosurg 958 Jin Guang Rd Shanghai Peoples R China|Fudan Univ Neurosurg Inst Shanghai Peoples R China|Shanghai Clin Med Ctr Neurosurg Shanghai Peoples R China|Shanghai Pituitary Tumor Ctr Shanghai Peoples R China;
机译:一种新型嵌合分子靶向生长抑制素和多巴胺受体对生长激素分泌垂体腺瘤的疗效作用
机译:临床上无功能的垂体腺瘤的术后生长激素动力学
机译:circOMA1介导的miR-145-5p通过靶向TPT1抑制非功能性垂体腺瘤的肿瘤生长
机译:巨型无耳垂体腺瘤的外科策略
机译:人类生长激素释放激素转基因小鼠的垂体前叶垂体激素分泌,表达和细胞数量的可塑性:专注于甘丙肽,生长激素和催乳激素。
机译:靶向生长抑素和多巴胺受体的新型嵌合分子对生长激素分泌垂体腺瘤的治疗作用。
机译:BRD4作为无障碍和生长激素垂体腺瘤的治疗靶标